In the United States, cannabis is currently illegal, but this book investigates how big pharmaceutical companies are looking at an end-game of legality—controlled by them. It examines how the Amsterdam scene has been transformed; how home growers have been manipulated into using inferior techniques; and how companies, with help from the Drug Enforcement Agency (DEA) and “big pharma,†are patenting cannabis strains for control and profit. The leadership of the cannabis industry want to legalize marijuana with taxation and regulation, but the pharmaceutical industry cannot take over medical cannabis without first shutting down the scene today. The book predicts that legalized production will be tightly controlled by major players, using the IRS and DEA as a means of removing other growers. Regulation will also control the amount of tetrahydrocannabinol (THC) in each marijuana cigarette, forcing stronger cannabis to be available to medical patients by prescription only. A black market will still exist, so people will still go to jail, and the drug war will go on. With history and explosive, behind-the-scenes looks at big pharma collusion, this book is both an exposé and an in-depth look at the arc of freedom and probable control through use of pharmaceutical patents for marijuana.
The 15 Ounce Pound: Big Pharma's Plan to Patent Pot
📄 Viewing lite version
Full site ›
Book Details
Author(s)Joseph R. Pietri
PublisherTrine Day
ISBN / ASIN1937584143
ISBN-139781937584146
AvailabilityUsually ships in 24 hours
Sales Rank1,449,269
CategoryBusiness & Economics
MarketplaceUnited States 🇺🇸
Description ▲
More Books in Business & Economics
Culture and Business in Asia
View
How to Raise Goats: Everything You Need to Know, Updat…
View
How To Set Up and Maintain a BETTER Voiceover Business…
View
Data Warehousing and Knowledge Discovery: 8th Internat…
View
The Dixification of America: The American Odyssey into…
View
Cash Flow Strategies: Learn to start a business and ma…
View
Las lecturas diarias de Maxwell (Spanish Edition)
View
Traderevolution: Training for Traders
View